{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:37:33Z","timestamp":1761514653575,"version":"3.40.5"},"reference-count":54,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T00:00:00Z","timestamp":1604275200000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873565","81770575","81970511"],"award-info":[{"award-number":["81873565","81770575","81970511"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Digest Diseases"],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:p>Non\u2010alcoholic fatty liver disease (NAFLD) is now the most common etiology of chronic liver disease threatening global public health. However, the name \u201cNAFLD\u201d is no longer appropriate with the change of time. Recently, a new term, \u201cmetabolic dysfunction\u2010associated fatty liver disease\u201d has been proposed by an international panel of experts, which implies profound conceptual changes in terms of its metabolism\u2010related etiology and disease heterogeneity. In this article we discuss the specific conceptual changes that clinicians, researchers and patients must absorb.<\/jats:p>","DOI":"10.1111\/1751-2980.12944","type":"journal-article","created":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T08:27:43Z","timestamp":1601022463000},"page":"604-609","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["<scp>Non\u2010alcoholic fatty liver disease to metabolic dysfunction\u2010associated fatty liver disease<\/scp>: Conceptual changes for clinicians, researchers and patients"],"prefix":"10.1111","volume":"21","author":[{"given":"Shuang Zhe","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Gastroenterology Xin Hua Hospital affiliated to Shanghai Jiao Tong University School of Medicine  Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan Wen","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Xin Hua Hospital affiliated to Shanghai Jiao Tong University School of Medicine  Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8618-6402","authenticated-orcid":false,"given":"Jian Gao","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Xin Hua Hospital affiliated to Shanghai Jiao Tong University School of Medicine  Shanghai China"},{"name":"Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition  Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,11,2]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi Z","year":"2019","journal-title":"Hepatology"},{"key":"e_1_2_8_3_1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani N","year":"2018","journal-title":"Hepatology."},{"key":"e_1_2_8_4_1","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL\u2013EASD\u2013EASO clinical practice guidelines for the management of non\u2010alcoholic fatty liver disease","volume":"64","author":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO)","year":"2016","journal-title":"J Hepatol."},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2016.01.012"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-0315-7"},{"issue":"11","key":"e_1_2_8_7_1","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1172\/JCI107492","article-title":"Natural history of alcoholic hepatitis. IV. Glycosaminoglylcuronans and collagen in the hepatic connective tissue","volume":"52","author":"Galambos JT","year":"1973","journal-title":"J Clin Invest."},{"issue":"7","key":"e_1_2_8_8_1","first-page":"434","article-title":"Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease","volume":"55","author":"Ludwig J","year":"1980","journal-title":"Mayo Clin Proc."},{"key":"e_1_2_8_9_1","first-page":"283","article-title":"Nonalcoholic fatty liver disease","volume":"8","author":"Schaffner F","year":"1986","journal-title":"Prog Liver Dis."},{"key":"e_1_2_8_10_1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction\u2010associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam M","year":"2020","journal-title":"J Hepatol."},{"key":"e_1_2_8_11_1","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: A consensus\u2010driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam M","year":"2020","journal-title":"Gastroenterology."},{"key":"e_1_2_8_12_1","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/liv.14478","article-title":"What's in a name? Renaming \u2018NAFLD\u2019 to \u2018MAFLD","volume":"40","author":"Fouad Y","year":"2020","journal-title":"Liver Int."},{"key":"e_1_2_8_13_1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.dsx.2020.05.019","article-title":"From non\u2010alcoholic fatty liver disease (NAFLD) to metabolic\u2010associated fatty liver disease (MAFLD): a journey over 40\u2009years","volume":"14","author":"Kuchay MS","year":"2020","journal-title":"Diabetes Metab Syndr."},{"key":"e_1_2_8_14_1","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1111\/liv.14548","article-title":"Comparison of MAFLD and NAFLD diagnostic criteria in real world","volume":"40","author":"Lin S","year":"2020","journal-title":"Liver Int."},{"key":"e_1_2_8_15_1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S2468-1253(20)30091-1","article-title":"Redefining non\u2010alcoholic fatty liver disease: what's in a name?","volume":"5","year":"2020","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"e_1_2_8_16_1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41575-020-0316-6","article-title":"From NAFLD to MAFLD: when pathophysiology succeeds","volume":"17","author":"Tilg H","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"e_1_2_8_17_1","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1097\/CM9.0000000000000981","article-title":"From NAFLD to MAFLD: a \u201credefining\u201d moment for fatty liver disease","volume":"133","author":"Zheng KI","year":"2020","journal-title":"Chin Med J (Engl)."},{"key":"e_1_2_8_18_1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1751-2980.2010.00472.x","article-title":"Histopathological evaluation of fatty and alcoholic liver diseases","volume":"12","author":"Yerian L","year":"2011","journal-title":"J Dig Dis."},{"key":"e_1_2_8_19_1","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.2337\/dc20-S002","article-title":"Classification and diagnosis of diabetes: standards of medical care in diabetes\u20142020","volume":"43","author":"American Diabetes Association","year":"2020","journal-title":"Diabetes Care."},{"key":"e_1_2_8_20_1","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/hep.29055","article-title":"Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review","volume":"65","author":"Ajmera VH","year":"2017","journal-title":"Hepatology."},{"key":"e_1_2_8_21_1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jhep.2017.11.006","article-title":"The bidirectional impacts of alcohol consumption and the metabolic syndrome: cofactors for progressive fatty liver disease","volume":"68","author":"Boyle M","year":"2018","journal-title":"J Hepatol."},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2020.02.001"},{"key":"e_1_2_8_23_1","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.2174\/138161210794455067","article-title":"Chronic hepatitis C, insulin resistance and vascular disease","volume":"16","author":"Trpkovic A","year":"2010","journal-title":"Curr Pharm Des."},{"key":"e_1_2_8_24_1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12916-018-1103-x","article-title":"Real\u2010world data reveal a diagnostic gap in non\u2010alcoholic fatty liver disease","volume":"16","author":"Alexander M","year":"2018","journal-title":"BMC Med."},{"key":"e_1_2_8_25_1","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non\u2010alcoholic fatty liver disease and non\u2010alcoholic steatohepatitis in adults","volume":"34","author":"Vernon G","year":"2011","journal-title":"Aliment Pharmacol Ther."},{"journal-title":"Hepatology.","article-title":"From NAFLD to MAFLD: implications of a premature change in terminology","author":"Younossi ZM","key":"e_1_2_8_26_1"},{"key":"e_1_2_8_27_1","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1053\/j.gastro.2006.03.019","article-title":"Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease","volume":"130","author":"Church TS","year":"2006","journal-title":"Gastroenterology."},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i5.1650"},{"key":"e_1_2_8_29_1","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jhep.2019.06.023","article-title":"Prevalence of prediabetes and diabetes in children and adolescents with biopsy\u2010proven non\u2010alcoholic fatty liver disease","volume":"71","author":"Nobili V","year":"2019","journal-title":"J Hepatol."},{"key":"e_1_2_8_30_1","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jhep.2017.11.012","article-title":"Determinants of fibrosis progression and regression in NASH","volume":"68","author":"Schuppan D","year":"2018","journal-title":"J Hepatol."},{"key":"e_1_2_8_31_1","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1309\/EY72F1EN9XCB1KXX","article-title":"Fibrosis heterogeneity in nonalcoholic steatohepatitis and hepatitis C virus needle core biopsy specimens","volume":"123","author":"Goldstein NS","year":"2005","journal-title":"Am J Clin Pathol."},{"key":"e_1_2_8_32_1","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1053\/j.gastro.2005.03.084","article-title":"Sampling variability of liver biopsy in nonalcoholic fatty liver disease","volume":"128","author":"Ratziu V","year":"2005","journal-title":"Gastroenterology."},{"key":"e_1_2_8_33_1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3748\/wjg.v20.i2.475","article-title":"Limitations of liver biopsy and non\u2010invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"20","author":"Sumida Y","year":"2014","journal-title":"World J Gastroenterol."},{"key":"e_1_2_8_34_1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jhep.2020.04.011","article-title":"Animal models for liver disease \u2010 a practical approach for translational research","volume":"73","author":"Nevzorova YA","year":"2020","journal-title":"J Hepatol."},{"key":"e_1_2_8_35_1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/toxsci\/kfx253","article-title":"Asking the right questions with animal models: methionine\u2010 and choline\u2010deficient model in predicting adverse drug reactions in human NASH","volume":"161","author":"Li H","year":"2018","journal-title":"Toxicol Sci."},{"key":"e_1_2_8_36_1","doi-asserted-by":"crossref","first-page":"e0127991","DOI":"10.1371\/journal.pone.0127991","article-title":"Mouse models of diet\u2010induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease","volume":"10","author":"Machado MV","year":"2015","journal-title":"PLoS One."},{"key":"e_1_2_8_37_1","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/ajg.2015.235","article-title":"Prevalence and severity of nonalcoholic fatty liver disease in non\u2010obese patients: a population study using proton\u2010magnetic resonance spectroscopy","volume":"110","author":"Wei JL","year":"2015","journal-title":"Am J Gastroenterol."},{"key":"e_1_2_8_38_1","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","article-title":"New trends on obesity and NAFLD in Asia","volume":"67","author":"Fan JG","year":"2017","journal-title":"J Hepatol"},{"key":"e_1_2_8_39_1","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1038\/s41598-017-05040-6","article-title":"Metabolomic characteristics of cholesterol\u2010induced non\u2010obese nonalcoholic fatty liver disease in mice","volume":"7","author":"Tu LN","year":"2017","journal-title":"Sci Rep."},{"key":"e_1_2_8_40_1","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/hep.30908","article-title":"Lean NAFLD: a distinct entity shaped by differential metabolic adaptation","volume":"71","author":"Chen F","year":"2020","journal-title":"Hepatology."},{"key":"e_1_2_8_41_1","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jhep.2015.11.022","article-title":"Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome\u2010dependent mechanism","volume":"64","author":"Wan XY","year":"2016","journal-title":"J Hepatol."},{"key":"e_1_2_8_42_1","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.jhep.2020.02.020","article-title":"Update on NAFLD genetics: from new variants to the clinic","volume":"72","author":"Tr\u00e9po E","year":"2020","journal-title":"J Hepatol."},{"key":"e_1_2_8_43_1","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.27242","article-title":"Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis","volume":"61","author":"Smagris E","year":"2015","journal-title":"Hepatology."},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2019.01.013"},{"key":"e_1_2_8_45_1","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/01.HYP.0000161995.64192.2b","article-title":"A new transgenic rat model of hepatic steatosis and the metabolic syndrome","volume":"45","author":"Qi NR","year":"2005","journal-title":"Hypertension."},{"key":"e_1_2_8_46_1","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/hep.28472","article-title":"Carboxylesterase 2 prevents liver steatosis by modulating lipolysis, endoplasmic reticulum stress, and lipogenesis and is regulated by hepatocyte nuclear factor 4 alpha in mice","volume":"63","author":"Li YY","year":"2016","journal-title":"Hepatology"},{"key":"e_1_2_8_47_1","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1478-3231.2010.02264.x","article-title":"The challenge of developing novel pharmacological therapies for non\u2010alcoholic steatohepatitis","volume":"30","author":"Schuppan D","year":"2010","journal-title":"Liver Int."},{"key":"e_1_2_8_48_1","doi-asserted-by":"crossref","DOI":"10.1111\/liv.14623","article-title":"Concordance of MAFLD and NAFLD diagnostic criteria in \u201creal\u2010world\u201d data [published online ahead of print 16 June 2020]","author":"Targher G","year":"2020","journal-title":"Liver Int"},{"key":"e_1_2_8_49_1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12916-016-0647-x","article-title":"Real\u2010world data in the United Kingdom: opportunities and challenges","volume":"14","author":"McDonald L","year":"2016","journal-title":"BMC Med."},{"key":"e_1_2_8_50_1","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41571-019-0167-7","article-title":"Real\u2010world data: towards achieving the achievable in cancer care","volume":"16","author":"Booth CM","year":"2019","journal-title":"Nat Rev Clin Oncol."},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2017.07.015"},{"key":"e_1_2_8_52_1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12916-019-1321-x","article-title":"Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real\u2010world study of 18 million patients in four European cohorts","volume":"17","author":"Alexander M","year":"2019","journal-title":"BMC Med."},{"key":"e_1_2_8_53_1","doi-asserted-by":"crossref","unstructured":"FanJG WeiL ZhuangH;National Workshop on Fatty Liver and Alcoholic Liver Disease Chinese Society of Hepatology Chinese Medical Association; Fatty Liver Disease Expert Committee Chinese Medical Doctor Association. Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018 China).J Dig Dis. 2019;20(4):163\u2010173.","DOI":"10.1111\/1751-2980.12685"},{"key":"e_1_2_8_54_1","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.1097\/MCG.0000000000000075","article-title":"Low awareness of nonalcoholic fatty liver disease among patients at high metabolic risk","volume":"49","author":"Wieland AC","year":"2015","journal-title":"J Clin Gastroenterol."},{"key":"e_1_2_8_55_1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jhep.2019.08.027","article-title":"A cross\u2010sectional study of the public health response to non\u2010alcoholic fatty liver disease in Europe","volume":"72","author":"Lazarus JV","year":"2020","journal-title":"J Hepatol."}],"container-title":["Journal of Digestive Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1751-2980.12944","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/1751-2980.12944","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1751-2980.12944","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T15:36:51Z","timestamp":1693841811000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1751-2980.12944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":54,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["10.1111\/1751-2980.12944"],"URL":"https:\/\/doi.org\/10.1111\/1751-2980.12944","archive":["Portico"],"relation":{},"ISSN":["1751-2972","1751-2980"],"issn-type":[{"type":"print","value":"1751-2972"},{"type":"electronic","value":"1751-2980"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"2020-08-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}